08/ 31/ 2026
Loncom Pharma Visits CPHI Korea 2026 to Strengthen Pharmaceutical Partnerships in East Asia
Loncom Pharma visited CPHI Korea 2026 to engage with pharmaceutical partners, understand East Asian market needs, advance international collaboration.
07/ 29/ 2026
Loncom Pharma’s Ertugliflozin Tablets Approved in China
Loncom Pharma develops Ertugliflozin Tablets, showcasing integrated API, formulation, manufacturing, and generic drug expertise.
07/ 27/ 2026
FDA Updates ANDA Bioequivalence Guidance Aligning with ICH M13A: New Opportunities for Global Generic Drug Development
Loncom Pharma analyzes FDA ANDA bioequivalence updates and supports global generic drug development strategies.
